Publications & Reports

Treatment outcomes of patients switching from an injectable drug to bedaquiline during short standardized MDR-TB treatment in Mozambique.

Bastard M, Molfino L, Mutaquiha C, Galindo MA, Zindoga P, Vaz D, Mahinça I, du Cros P, Rusch B, Telnov A
Epicentre, Paris, France.


Bedaquiline was recommended by WHO as the preferred option in treatment of MDR-TB patients with long regimen. However, no recommendation was given for the short MDR-TB regimen. Data from our small cohort of patients who switched injectable dug to bedaquiline suggest that bedaquiline based short regimen is effective and safe.

Link to publisher’s web site


  • Journal: Clinical Infectious Diseases
  • Published: 11/03/2019
  • Volume: 69
  • Issue: 10
  • Pagination: 1809-1811